Breast Cancer Tumor Biology Characteristics and Its Correlation in a Tertiary Care Center

J. Sharma, Tapan Kapoor, Guman Singh, A. Loyal, D. Singh
{"title":"Breast Cancer Tumor Biology Characteristics and Its Correlation in a Tertiary Care Center","authors":"J. Sharma, Tapan Kapoor, Guman Singh, A. Loyal, D. Singh","doi":"10.5005/jp-journals-10057-0143","DOIUrl":null,"url":null,"abstract":"Ab s t r Ac t Aims/Objectives: The study aims to evaluate and correlate the relationship between hormone receptor status—estrogen, progesterone receptor (ER and PR), and Herceptin receptor (Her-2/neu) with tumor characteristics in breast cancer patients. Materials and methods: The current study included 101 breast cancer patients of various age-groups from the period 2016–2020. The tumors were evaluated for hormone expression, size, histologic grade, lymphovascular invasion, and axillary node status. The excised breast tissue specimen was evaluated for hormone status by immunohistochemistry (IHC) testing on paraffin blocks and was further analyzed using the fluorescence in situ hybridization (FISH) technique as per requirement. Stratification based on hormone receptor status was done in four categories—ER+PR+Her-2neu−, ER−PR−Her-2neu+, ER+PR+Her-2neu+, and ER−PR−Her-2neu−. Results: In this study, 37.6% of tumors were ER+PR+Her-2neu−, 13.8% ER−PR−Her-2neu+, 13.8% ER+PR+Her-2neu+, and 34.6% ER−PR−Her2neu−. Among high-grade tumors, more than half (52%) patients were hormone receptor-negative, whereas among low-grade tumors 55% of patients were hormone receptor-positive. Sixteen percent of patients presented with a younger age-group (<35 years) and in these patients, nearly 38% were Her-2/neu positive and most of the Her-2/neu receptor-positive patients (80%) had lymphovascular space invasion. Primary tumor size at time of presentation was <2 cm (T1) in only 11% of cases and 2–5 cm (T2) in 72% of cases. Lymph node positivity did not correlate with hormone receptor status. Conclusion: The incidence of Her2-neu positive breast cancer patients was higher in the Indian population as compared to the Western world. The current study depicts the distinct shift in terms of tumor stage and biology, higher rate of Her-2/neu-positivity, younger age at diagnosis, larger tumor size, advanced tumor grade, and more positive lymph node involvement in contrast to the Western population.","PeriodicalId":16223,"journal":{"name":"Journal of Mahatma Gandhi University of Medical Sciences and Technology","volume":"6 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Mahatma Gandhi University of Medical Sciences and Technology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5005/jp-journals-10057-0143","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Ab s t r Ac t Aims/Objectives: The study aims to evaluate and correlate the relationship between hormone receptor status—estrogen, progesterone receptor (ER and PR), and Herceptin receptor (Her-2/neu) with tumor characteristics in breast cancer patients. Materials and methods: The current study included 101 breast cancer patients of various age-groups from the period 2016–2020. The tumors were evaluated for hormone expression, size, histologic grade, lymphovascular invasion, and axillary node status. The excised breast tissue specimen was evaluated for hormone status by immunohistochemistry (IHC) testing on paraffin blocks and was further analyzed using the fluorescence in situ hybridization (FISH) technique as per requirement. Stratification based on hormone receptor status was done in four categories—ER+PR+Her-2neu−, ER−PR−Her-2neu+, ER+PR+Her-2neu+, and ER−PR−Her-2neu−. Results: In this study, 37.6% of tumors were ER+PR+Her-2neu−, 13.8% ER−PR−Her-2neu+, 13.8% ER+PR+Her-2neu+, and 34.6% ER−PR−Her2neu−. Among high-grade tumors, more than half (52%) patients were hormone receptor-negative, whereas among low-grade tumors 55% of patients were hormone receptor-positive. Sixteen percent of patients presented with a younger age-group (<35 years) and in these patients, nearly 38% were Her-2/neu positive and most of the Her-2/neu receptor-positive patients (80%) had lymphovascular space invasion. Primary tumor size at time of presentation was <2 cm (T1) in only 11% of cases and 2–5 cm (T2) in 72% of cases. Lymph node positivity did not correlate with hormone receptor status. Conclusion: The incidence of Her2-neu positive breast cancer patients was higher in the Indian population as compared to the Western world. The current study depicts the distinct shift in terms of tumor stage and biology, higher rate of Her-2/neu-positivity, younger age at diagnosis, larger tumor size, advanced tumor grade, and more positive lymph node involvement in contrast to the Western population.
三级保健中心乳腺癌肿瘤生物学特征及其相关性研究
目的/目的:本研究旨在评价乳腺癌患者激素受体状态——雌激素、孕激素受体(ER和PR)、赫赛汀受体(Her-2/neu)与肿瘤特征的关系,并探讨其相关性。材料与方法:本研究纳入了2016-2020年期间101例不同年龄段的乳腺癌患者。评估肿瘤的激素表达、大小、组织学分级、淋巴血管浸润和腋窝淋巴结状态。切除乳腺组织标本石蜡块免疫组化(IHC)检测激素状态,并按要求采用荧光原位杂交(FISH)技术进一步分析。基于激素受体状态的分层分为四类:ER+PR+Her-2neu -, ER - PR - Her-2neu+, ER+PR+Her-2neu+和ER - PR - Her-2neu -。结果:本组肿瘤中ER+PR+Her-2neu−占37.6%,ER - PR - Her-2neu+占13.8%,ER+PR+Her-2neu+占13.8%,ER - PR - Her2neu−占34.6%。高档肿瘤中,一半以上(52%)患者激素受体阴性,而低级的肿瘤中55%的患者激素受体阳性。16%的患者出现在较年轻的年龄组(<35岁),在这些患者中,近38%的Her-2/neu阳性,大多数Her-2/neu受体阳性的患者(80%)有淋巴血管间隙浸润。原发肿瘤大小在演讲时间< 2厘米(T1)只有11%的情况下,2 - 5厘米(T2)在72%的情况下。淋巴结阳性与激素受体状态无关。结论:与西方国家相比,印度人群中Her2-neu阳性乳腺癌患者的发病率更高。当前的研究描述了不同的转移肿瘤阶段和生物学而言,更高的her - 2 / neu-positivity,年轻在诊断、较大的肿瘤大小,淋巴结先进肿瘤品位,更积极与西方人口。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信